KPTA to call for more investment-oriented government policies in R&D

In its meeting of Board of Directors on May 29, the Korean Pharmaceutical Manufacturers Association (KPMA) has recently criticized the government's drug-related policies to arbitrarily lower the insurance drug prices for better finance stability in the national health insurance sector and instead, the government will endeavor to foster the domestic pharmaceutical industry as one of the national...